 NESS ZIONA, Israel, Nov. 09, 2020 GLOBE NEWSWIRE -- Sol-Gel Technologies NASDAQ: SLGL, Sol-Gel, a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the company will present at the following upcoming virtual investor conferences. 